4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001799191-22-000037
Chief Operating Officer acquired 23,607 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Matthew P Chief Operating Officer | 2022-11-17 | Grant or award | +23,607 | 101,641 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Miller Matthew P Chief Operating Officer | 2022-11-17 | Grant or award · Non-Qualified Stock Option (right to buy) | +119,825 | 119,825 | D: show line 2 in the form |
Loading xslF345X03/edgardoc.xml…